Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of quercetin under different administration forms and antihypertensive effects
2008-001176-67Phase 2Active
- Sponsor
- Dr. Antonio Osuna Ortega
- Start
- Sep 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of quercetin in essential hypertension, sponsored by Dr. Antonio Osuna Ortega. Primary endpoint: Systolic blood pressure level. Started Sep 2008; status: active.
02
Drugs
quercetin
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2008-001176-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001176-67.